Discover open access scientific publications

Search, annotate, share and cite publications

Publications by A. V. Zilov

The Use of Ultra-Long-Acting Insulin Analogue Degludec in Type 1 Diabetes Mellitus in Clinical Practice: The Influence on Quality of Life and Satisfaction With Treatment

Almanac of Clinical Medicine

2016

English

Related publications

Effect of Switching Basal Insulin Regimen to Degludec on Quality of Life in Japanese Patients With Type 1 and Type 2 Diabetes Mellitus

Journal of Pharmaceutical Health Care and Sciences

2015

English

Design of the Novel Protraction Mechanism of Insulin Degludec, an Ultra-Long-Acting Basal Insulin

Pharmaceutical Research

Pharmaceutical Science

2012

English

Cost Analysis of Insulin Degludec in Comparison With Insulin Glargine U100 in the Treatment of Type 1 Diabetes Mellitus in the Brazilian Private Health Care System

English

Clinical and Cost Implications of Insulin Degludec in Patients With Type 1 Diabetes and Problematic Hypoglycemia: A Quality Improvement Project

English

A Survey of Physician Experience and Treatment Satisfaction Using Fast-Acting Insulin Aspart in People With Type 1 or Type 2 Diabetes

Postgraduate Medicine

Medicine

2020

English

Cost-Effectiveness of Insulin Degludec Compared With Insulin Glargine for Patients With Type 2 Diabetes Mellitus Initiating Insulin Therapy in the United Kingdom

English

The Relationship of Depression to Treatment Adherence, Quality of Life and Health Outcomes in Type 1 Diabetes Mellitus

E-Journal of Applied Psychology

2006

English

Health-Related Quality of Life, Treatment Satisfaction, and Costs Associated With Intraperitoneal Versus Subcutaneous Insulin Administration in Type 1 Diabetes: A Randomized Controlled Trial

English

Use of Fast‐acting Insulin Aspart in Insulin Pump Therapy in Clinical Practice

Diabetes, Obesity and Metabolism

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by A. V. Zilov

The Use of Ultra-Long-Acting Insulin Analogue Degludec in Type 1 Diabetes Mellitus in Clinical Practice: The Influence on Quality of Life and Satisfaction With Treatment

Related publications

Effect of Switching Basal Insulin Regimen to Degludec on Quality of Life in Japanese Patients With Type 1 and Type 2 Diabetes Mellitus

Design of the Novel Protraction Mechanism of Insulin Degludec, an Ultra-Long-Acting Basal Insulin

Cost Analysis of Insulin Degludec in Comparison With Insulin Glargine U100 in the Treatment of Type 1 Diabetes Mellitus in the Brazilian Private Health Care System

Clinical and Cost Implications of Insulin Degludec in Patients With Type 1 Diabetes and Problematic Hypoglycemia: A Quality Improvement Project

A Survey of Physician Experience and Treatment Satisfaction Using Fast-Acting Insulin Aspart in People With Type 1 or Type 2 Diabetes

Cost-Effectiveness of Insulin Degludec Compared With Insulin Glargine for Patients With Type 2 Diabetes Mellitus Initiating Insulin Therapy in the United Kingdom

The Relationship of Depression to Treatment Adherence, Quality of Life and Health Outcomes in Type 1 Diabetes Mellitus

Health-Related Quality of Life, Treatment Satisfaction, and Costs Associated With Intraperitoneal Versus Subcutaneous Insulin Administration in Type 1 Diabetes: A Randomized Controlled Trial

Use of Fast‐acting Insulin Aspart in Insulin Pump Therapy in Clinical Practice